PETV Stock Overview
A biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
PetVivo Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.77 |
| 52 Week High | US$0.98 |
| 52 Week Low | US$0.29 |
| Beta | 0.79 |
| 1 Month Change | 38.38% |
| 3 Month Change | 28.17% |
| 1 Year Change | 6.76% |
| 3 Year Change | -44.28% |
| 5 Year Change | -31.34% |
| Change since IPO | -99.09% |
Recent News & Updates
Recent updates
Companies Like PetVivo Holdings (NASDAQ:PETV) Could Be Quite Risky
Nov 11
Will PetVivo Holdings (NASDAQ:PETV) Spend Its Cash Wisely?
Jul 26PetVivo Holdings GAAP EPS of -$0.57 beats by $0.37, revenue of $0.1M misses by $1.6M
Jun 29We Think PetVivo Holdings (NASDAQ:PETV) Can Afford To Drive Business Growth
Mar 23Shareholder Returns
| PETV | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 7.3% | 1.5% | 2.9% |
| 1Y | 6.8% | 9.9% | 11.9% |
Return vs Industry: PETV underperformed the US Medical Equipment industry which returned 9.9% over the past year.
Return vs Market: PETV underperformed the US Market which returned 11.9% over the past year.
Price Volatility
| PETV volatility | |
|---|---|
| PETV Average Weekly Movement | 12.9% |
| Medical Equipment Industry Average Movement | 9.5% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 4.2% |
Stable Share Price: PETV's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: PETV's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 20 | John Lai | www.petvivo.com |
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company’s pipeline products also include therapeutic devices for veterinary and human clinical applications.
PetVivo Holdings, Inc. Fundamentals Summary
| PETV fundamental statistics | |
|---|---|
| Market cap | US$18.64m |
| Earnings (TTM) | -US$8.63m |
| Revenue (TTM) | US$956.05k |
19.5x
P/S Ratio-2.2x
P/E RatioIs PETV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PETV income statement (TTM) | |
|---|---|
| Revenue | US$956.05k |
| Cost of Revenue | US$228.19k |
| Gross Profit | US$727.86k |
| Other Expenses | US$9.36m |
| Earnings | -US$8.63m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.36 |
| Gross Margin | 76.13% |
| Net Profit Margin | -902.71% |
| Debt/Equity Ratio | -189.0% |
How did PETV perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/19 10:45 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PetVivo Holdings, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ashok Kumar | ThinkEquity LLC |